Research Analysts Offer Predictions for SBC FY2026 Earnings

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Stock analysts at Zacks Research lifted their FY2026 EPS estimates for shares of SBC Medical Group in a research note issued to investors on Tuesday, May 19th. Zacks Research analyst M. Marin now forecasts that the company will post earnings of $0.49 per share for the year, up from their previous forecast of $0.46. The consensus estimate for SBC Medical Group’s current full-year earnings is $0.45 per share.

Several other research analysts have also commented on the company. Weiss Ratings upgraded SBC Medical Group from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 8th. BTIG Research assumed coverage on SBC Medical Group in a report on Friday, March 6th. They set a “buy” rating and a $8.00 price target on the stock. Finally, Wall Street Zen upgraded SBC Medical Group to a “hold” rating in a report on Saturday, May 9th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $8.50.

SBC Medical Group Trading Down 4.0%

Shares of SBC opened at $3.10 on Friday. SBC Medical Group has a 52-week low of $2.78 and a 52-week high of $5.75. The company has a quick ratio of 3.78, a current ratio of 3.82 and a debt-to-equity ratio of 0.12. The firm’s fifty day moving average is $3.69 and its two-hundred day moving average is $3.92. The stock has a market cap of $318.00 million, a PE ratio of 7.95 and a beta of 0.61.

SBC Medical Group (NASDAQ:SBC) last announced its earnings results on Thursday, May 14th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.01. SBC Medical Group had a net margin of 24.09% and a return on equity of 15.90%. The company had revenue of $43.06 million for the quarter, compared to analysts’ expectations of $41.66 million.

Insider Activity at SBC Medical Group

In other news, CEO Yoshiyuki Aikawa sold 4,422,900 shares of SBC Medical Group stock in a transaction on Friday, March 6th. The stock was sold at an average price of $2.12, for a total transaction of $9,376,548.00. Following the transaction, the chief executive officer owned 861,600 shares in the company, valued at $1,826,592. The trade was a 83.70% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In the last 90 days, insiders sold 7,987,900 shares of company stock worth $20,142,848. 89.47% of the stock is owned by insiders.

Institutional Trading of SBC Medical Group

Institutional investors and hedge funds have recently bought and sold shares of the stock. Bank of New York Mellon Corp purchased a new stake in SBC Medical Group in the 1st quarter valued at about $43,000. Goldman Sachs Group Inc. purchased a new stake in SBC Medical Group in the 4th quarter valued at about $49,000. Russell Investments Group Ltd. raised its holdings in SBC Medical Group by 292.0% in the 4th quarter. Russell Investments Group Ltd. now owns 11,775 shares of the company’s stock valued at $51,000 after buying an additional 8,771 shares during the period. Nuveen LLC purchased a new stake in SBC Medical Group in the 4th quarter valued at about $53,000. Finally, Wells Fargo & Company MN raised its holdings in SBC Medical Group by 195.1% in the 4th quarter. Wells Fargo & Company MN now owns 12,626 shares of the company’s stock valued at $54,000 after buying an additional 8,348 shares during the period. 60.82% of the stock is currently owned by hedge funds and other institutional investors.

About SBC Medical Group

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.